Novartis AG - 28 Year Stock Price History | NVS

Historical daily share price chart and data for Novartis AG since 1996 adjusted for splits and dividends. The latest closing stock price for Novartis AG as of February 29, 2024 is 100.97.
  • The all-time high Novartis AG stock closing price was 108.47 on January 22, 2024.
  • The Novartis AG 52-week high stock price is 108.78, which is 7.7% above the current share price.
  • The Novartis AG 52-week low stock price is 79.98, which is 20.8% below the current share price.
  • The average Novartis AG stock price for the last 52 weeks is 99.02.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Novartis AG Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 104.5141 101.0000 108.4700 99.0500 100.9700 0.00%
2023 95.7065 88.3787 105.1300 79.8293 100.9700 16.12%
2022 81.2056 80.8626 89.8547 71.5100 86.9506 8.02%
2021 80.4010 83.6398 87.5528 73.3441 80.4945 -3.82%
2020 76.9602 81.1574 84.6276 62.6345 83.6929 3.41%
2019 73.2936 63.0837 81.5164 63.0837 80.9351 25.68%
2018 61.7474 61.3397 68.6896 54.3633 64.3970 5.88%
2017 58.0319 50.9282 62.7667 48.9702 60.8181 19.40%
2016 53.3652 57.7731 58.3965 47.2640 50.9352 -12.13%
2015 65.2700 60.4508 71.4972 56.5671 57.9685 -4.53%
2014 57.4432 49.9159 63.3341 49.5862 60.7195 19.13%
2013 46.1066 38.9962 50.9748 38.9168 50.9685 31.80%
2012 34.9161 34.0239 39.0756 31.4511 38.6724 15.67%
2011 33.3545 33.2190 37.7316 30.2052 33.4333 1.14%
2010 29.5901 28.4592 33.5162 24.5497 33.0563 12.27%
2009 24.0144 25.6623 30.3796 18.3706 29.4437 14.23%
2008 26.6084 27.4625 31.6298 22.7148 25.7762 -5.69%
2007 27.8547 28.7130 29.7070 25.9678 27.3316 -3.65%
2006 27.7795 25.9705 30.2439 25.6313 28.3673 11.29%
2005 24.0526 23.9990 26.5679 22.2209 25.4897 5.64%
2004 21.8949 21.5281 24.1661 19.7167 24.1279 12.10%
2003 18.2654 17.0705 21.5234 15.0000 21.5234 27.36%
2002 17.9086 16.2532 20.1671 15.5765 16.9003 1.96%
2001 17.3295 20.0716 20.1567 14.9771 16.5756 -17.31%
2000 16.1518 15.6867 20.0447 12.9116 20.0447 26.91%
1999 16.9020 22.0775 22.2908 15.0657 15.7945 -24.44%
1998 18.1951 17.4217 21.4909 15.4116 20.9043 21.46%
1997 14.8647 11.3381 17.8722 10.8419 17.2102 50.81%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $216.666B $45.440B
Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy, Radioligand Therapy, and xRNA. Novartis efforts to strengthen its wide and deep oncology portfolio by developing breakthrough treatments. Cosentyx, Entresto, Kesimpta, Zolgensma, Kisqali and Leqvio. In March 2015, Novartis acquired certain oncology products and pipeline compounds from Glaxo. In exchange, it sold its non-influenza Vaccines business to Glaxo. Also, the company has spun off the Alcon business into a separate company. In January 2015, Novartis divested its Animal Health division to Lilly. In July 2015, the company divested its influenza vaccines business to CSL Limited. Novartis has also acquired The Medicines Company, adding Leqvio, to its portfolio. Novartis sold its investment in Roche.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $719.883B 119.88
Novo Nordisk (NVO) Denmark $545.415B 44.93
Johnson & Johnson (JNJ) United States $389.136B 15.49
Merck (MRK) United States $324.660B 85.46
AbbVie (ABBV) United States $314.432B 16.02
AstraZeneca (AZN) United Kingdom $202.610B 17.95
Pfizer (PFE) United States $152.689B 14.78
Sanofi (SNY) $121.420B 10.93
Innoviva (INVA) United States $0.984B 8.87